BlackRock’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-13,385,970
| Closed | -$1.14B | – | 5269 |
|
|
2020
Q3 | $1.14B | Sell |
13,385,970
-728,256
| -5% | -$36.8M | 0.04% | 413 |
|
|
2020
Q2 | $500M | Sell |
14,114,226
-1,663,667
| -11% | -$48.6M | 0.02% | 711 |
|
|
2020
Q1 | $213M | Buy |
15,777,893
+1,081,297
| +7% | +$18.2M | 0.01% | 1119 |
|
|
2019
Q4 | $311M | Buy |
14,696,596
+460,527
| +3% | +$8.12M | 0.01% | 1160 |
|
|
2019
Q3 | $189M | Buy |
14,236,069
+437,266
| +3% | +$6.43M | 0.01% | 1445 |
|
|
2019
Q2 | $191M | Buy |
13,798,803
+1,239,462
| +10% | +$18.7M | 0.01% | 1468 |
|
|
2019
Q1 | $241M | Sell |
12,559,341
-80,009
| -0.6% | -$1.29M | 0.01% | 1268 |
|
|
2018
Q4 | $180M | Buy |
12,639,350
+435,568
| +4% | +$8.65M | 0.01% | 1397 |
|
|
2018
Q3 | $254M | Buy |
12,203,782
+974,954
| +9% | +$23.1M | 0.01% | 1293 |
|
|
2018
Q2 | $266M | Buy |
11,228,828
+2,195,066
| +24% | +$44.1M | 0.01% | 1232 |
|
|
2018
Q1 | $132M | Sell |
9,033,762
-30,497
| -0.3% | -$498K | 0.01% | 1649 |
|
|
2017
Q4 | $146M | Buy |
9,064,259
+736,608
| +9% | +$8.69M | 0.01% | 1602 |
|
|
2017
Q3 | $116M | Buy |
8,327,651
+95,208
| +1% | +$949K | 0.01% | 1752 |
|
|
2017
Q2 | $72.7M | Buy |
8,232,443
+315,950
| +4% | +$2.22M | ﹤0.01% | 2005 |
|
|
2017
Q1 | $51.2M | Buy |
7,916,493
+7,907,956
| +92,632% | +$40.1M | ﹤0.01% | 2202 |
|
|
2016
Q4 | $32K | Sell |
8,537
-93
| -1% | -$275 | ﹤0.01% | 3117 |
|
|
2016
Q3 | $28K | Hold |
8,630
| – | – | ﹤0.01% | 3207 |
|
|
2016
Q2 | $20K | Buy |
8,630
+3,141
| +57% | +$10.5K | ﹤0.01% | 3270 |
|
|
2016
Q1 | $14K | Buy |
5,489
+3,644
| +198% | +$8.2K | ﹤0.01% | 3021 |
|
|
2015
Q4 | $6K | Hold |
1,845
| – | – | ﹤0.01% | 3109 |
|
|
2015
Q3 | $3K | Hold |
1,845
| – | – | ﹤0.01% | 3134 |
|
|
2015
Q2 | $7K | Sell |
1,845
-370
| -17% | -$1.51K | ﹤0.01% | 3018 |
|
|
2015
Q1 | $8K | Hold |
2,215
| – | – | ﹤0.01% | 2870 |
|
|
2014
Q4 | $11K | Hold |
2,215
| – | – | ﹤0.01% | 2731 |
|
|
2014
Q3 | $8K | Hold |
2,215
| – | – | ﹤0.01% | 2883 |
|
|
2014
Q2 | $8K | Buy |
2,215
+141
| +7% | +$518 | ﹤0.01% | 2954 |
|
|
2014
Q1 | $9K | Hold |
2,074
| – | – | ﹤0.01% | 2807 |
|
|
2013
Q4 | $10K | Hold |
2,074
| – | – | ﹤0.01% | 2736 |
|
|
2013
Q3 | $13K | Hold |
2,074
| – | – | ﹤0.01% | 2506 |
|
|
2013
Q2 | $11K | Buy |
+2,074
| New | +$6.81K | ﹤0.01% | 2609 |
|
BlackRock's IMMU Position: Q4 2020 in Review
BlackRock sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 13,385,970 shares — an estimated $1.14B sold.
BlackRock first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $1.14B in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- BlackRock reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- BlackRock sold 13,385,970 Immunomedics Inc shares in Q4 2020, an estimated $1.14B.
- BlackRock first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- BlackRock's Immunomedics Inc position peaked at $1.14B in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on BlackRock's 13F filing for Q4 2020, filed 5 Feb 2021.